Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis

BACKGROUND: The benefit of adjuvant chemotherapy (AC) after pancreatoduodenectomy (PD) for ampullary adenocarcinoma is uncertain. We aimed to evaluate the association of AC with survival in patients with resected ampullary adenocarcinoma. METHODS: Using the National Cancer Database (NCDB) data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamarajah, Sivesh K., Bednar, Filip, Cho, Clifford S., Nathan, Hari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275534/
https://www.ncbi.nlm.nih.gov/pubmed/33230687
http://dx.doi.org/10.1007/s11605-020-04879-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275534/
https://www.ncbi.nlm.nih.gov/pubmed/33230687
http://dx.doi.org/10.1007/s11605-020-04879-x

Ejemplares similares